Wells Fargo’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $580K | Buy |
36,273
+7,480
| +26% | +$120K | ﹤0.01% | 3681 |
|
|
2025
Q1 | $492K | Buy |
28,793
+730
| +3% | +$12.5K | ﹤0.01% | 3693 |
|
|
2024
Q4 | $695K | Buy |
28,063
+9,349
| +50% | +$232K | ﹤0.01% | 3507 |
|
|
2024
Q3 | $534K | Sell |
18,714
-773
| -4% | -$22K | ﹤0.01% | 3589 |
|
|
2024
Q2 | $514K | Buy |
19,487
+1,825
| +10% | +$48.2K | ﹤0.01% | 3560 |
|
|
2024
Q1 | $571K | Buy |
17,662
+1,191
| +7% | +$38.5K | ﹤0.01% | 3466 |
|
|
2023
Q4 | $694K | Sell |
16,471
-50,543
| -75% | -$2.13M | ﹤0.01% | 3321 |
|
|
2023
Q3 | $2.57M | Sell |
67,014
-258
| -0.4% | -$9.91K | ﹤0.01% | 2429 |
|
|
2023
Q2 | $1.28M | Buy |
67,272
+3,995
| +6% | +$75.8K | ﹤0.01% | 3105 |
|
|
2023
Q1 | $981K | Buy |
+63,277
| New | +$981K | ﹤0.01% | 3176 |
|
|
2022
Q4 | – | Sell |
-123
| Closed | -$1K | – | 7239 |
|
|
2022
Q3 | $1K | Sell |
123
-397
| -76% | -$3.23K | ﹤0.01% | 6032 |
|
|
2022
Q2 | $2K | Buy |
+520
| New | +$2K | ﹤0.01% | 6032 |
|
|
2022
Q1 | – | Sell |
-12,423
| Closed | -$105K | – | 6929 |
|
|
2021
Q4 | $105K | Buy |
12,423
+12,370
| +23,340% | +$105K | ﹤0.01% | 5202 |
|
|
2021
Q3 | $0 | Sell |
53
-30,357
| -100% | – | ﹤0.01% | 6861 |
|
|
2021
Q2 | $321K | Sell |
30,410
-32,287
| -51% | -$341K | ﹤0.01% | 4550 |
|
|
2021
Q1 | $1.01M | Buy |
62,697
+22,581
| +56% | +$362K | ﹤0.01% | 3984 |
|
|
2020
Q4 | $1.85M | Sell |
40,116
-23,931
| -37% | -$1.11M | ﹤0.01% | 3507 |
|
|
2020
Q3 | $2.25M | Buy |
64,047
+20,967
| +49% | +$738K | ﹤0.01% | 3168 |
|
|
2020
Q2 | $1.05M | Buy |
+43,080
| New | +$1.05M | ﹤0.01% | 3690 |
|